Nical trial reported therapeutic rewards for use of 1 in nonsmall cell lung cancer [31,32],
Nical trial reported therapeutic rewards for use of 1 in nonsmall cell lung cancer , and bexarotene can be prescribed off-label for this disease. A mounting variety of studies have…